litlas
Log inCreate account

Richard C. Mulligan

Active 1974–2014

105
Papers
48,870
Citations
93
h-index
105
i10-index

Citations

Citations per year for Richard C. Mulligan1975: 2 citations1976: 11 citations1977: 8 citations1978: 9 citations1979: 9 citations1980: 14 citations1981: 21 citations1982: 39 citations1983: 37 citations1984: 49 citations1985: 68 citations1986: 121 citations1987: 167 citations1988: 190 citations1989: 192 citations1990: 258 citations1991: 217 citations1992: 286 citations1993: 255 citations1994: 292 citations1995: 353 citations1996: 388 citations1997: 403 citations1998: 420 citations1999: 451 citations2000: 550 citations2001: 552 citations2002: 657 citations2003: 675 citations2004: 615 citations2005: 619 citations2006: 608 citations2007: 479 citations2008: 479 citations2009: 441 citations2010: 406 citations2011: 348 citations2012: 320 citations2013: 271 citations2014: 231 citations2015: 213 citations2016: 198 citations2017: 157 citations2018: 149 citations2019: 445 citations2020: 408 citations2021: 392 citations2022: 283 citations2023: 207 citations2024: 259 citations2025: 116 citations2026: 2 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 7,357 citing papers, 45.8% of this breakdownUnited Kingdom: 985 citing papers, 6.1% of this breakdownGermany: 892 citing papers, 5.6% of this breakdownJapan: 784 citing papers, 4.9% of this breakdownCanada: 687 citing papers, 4.3% of this breakdownFrance: 622 citing papers, 3.9% of this breakdownChina: 548 citing papers, 3.4% of this breakdownItaly: 500 citing papers, 3.1% of this breakdownAustralia: 385 citing papers, 2.4% of this breakdownSwitzerland: 372 citing papers, 2.3% of this breakdownNetherlands: 344 citing papers, 2.2% of this breakdownBelgium: 243 citing papers, 1.5% of this breakdown
0%45.8%Other 14.5%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology43.3%
  • Medicine35.4%
  • Immunology and Microbiology13.3%
  • Neuroscience3.2%
  • Engineering1.8%
  • Materials Science1.3%
  • Other1.7%

Topics

  • Virus-based gene therapy research5%
  • RNA Interference and Gene Delivery3.1%
  • Immunotherapy and Immune Responses2.9%
  • CRISPR and Genetic Engineering2.7%
  • Mesenchymal stem cell research2.2%
  • Immune Cell Function and Interaction2.1%
  • Other82%

Coauthors

All papers

Open in search
  1. In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector

    Authors: Luigi Naldini, Ulrike Blömer, Philippe Gallay, Daniel Ory, Richard C. Mulligan, Fred H. Gage, Inder M. Verma, Didier Trono - Science 1996 cited by 4,928

  2. Engineering vascularized skeletal muscle tissue

    Authors: Shulamit Levenberg, Jeroen Rouwkema, Mara Macdonald, Evan S. Garfein, Daniel S. Kohane, Diane C. Darland, Robert P. Marini, Clemens van Blitterswijk, Richard C. Mulligan, Patrìcia A. D'Amore, Róbert Langer - Nature Biotechnology 2005 cited by 1,283

  3. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.

    Authors: Glen Dranoff, Elizabeth M. Jaffee, A Lazenby, Paul T. Golumbek, Hy Levitsky, Katja Brose, Violeta Jackson, Hirotaka Hamada, Drew M. Pardoll, Richard C. Mulligan - National Academy of Sciences, Proceedings of the National Academy of Sciences 1993 cited by 2,830

  4. Involvement of Granulocyte-Macrophage Colony-Stimulating Factor in Pulmonary Homeostasis

    Authors: Glenn Dranoff, Alexander D. Crawford, Michel Sadelain, Beverly Ream, Asif Rashid, Roderick T. Bronson, G. Richard Dickersin, Cindy J. Bachurski, E. L. Mark, Jeffrey A. Whitsett, Richard C. Mulligan - Science 1994 cited by 900

  5. PTH/PTHrP Receptor in Early Development and Indian Hedgehog—Regulated Bone Growth

    Authors: Beate Lanske, Andrew C. Karaplis, Kaechong Lee, Arne Luz, Andrea Vortkamp, Alison E. Pirro, Marcel Karperien, Libert H.K. Defize, Chrystal Ho, Richard C. Mulligan, Abdul‐Badi Abou‐Samra, Harald Jüppner, Gino V. Segre, Henry M. Kronenberg - Science 1996 cited by 1,338

  6. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo.

    Authors: Margaret A. Goodell, Katja Brose, G Paradis, Amy Conner, Richard C. Mulligan - The Journal of Experimental Medicine 1996 cited by 2,901

  7. Endothelial protein C receptor (CD201) explicitly identifies hematopoietic stem cells in murine bone marrow

    Authors: Alejandro B. Balazs, Attila J. Fabian, Charles T. Esmon, Richard C. Mulligan - Blood 2005 cited by 338

  8. Bioactive murine and human interleukin-12 fusion proteins which retain antitumor activity in vivo

    Authors: Graham J. Lieschke, Prakash K. Rao, Maurice K. Gately, Richard C. Mulligan - Nature Biotechnology 1997 cited by 157

  9. Demonstration That CFTR Is a Chloride Channel by Alteration of Its Anion Selectivity

    Authors: Matthew P. Anderson, Richard J. Gregory, Simon Thompson, David W. Souza, Sucharita Paul, Richard C. Mulligan, Alan E. Smith, Michael J. Welsh - Science 1991 cited by 1,140

  10. The Basic Science of Gene Therapy

    Authors: Richard C. Mulligan - Science 1993 cited by 1,765

  11. "Stemness": Transcriptional Profiling of Embryonic and Adult Stem Cells

    Authors: Miguel Ramalho‐Santos, Soonsang Yoon, Yumi Matsuzaki, Richard C. Mulligan, Douglas A. Melton - Science 2002 cited by 1,710

  12. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes.

    Authors: Daniel Ory, Beverly I. Neugeboren, Richard C. Mulligan - National Academy of Sciences, Proceedings of the National Academy of Sciences 1996 cited by 926

  13. Heterogeneity of the Angiogenic Response Induced in Different Normal Adult Tissues by Vascular Permeability Factor/Vascular Endothelial Growth Factor

    Authors: Ånna Pettersson, Janice A. Nagy, Lawrence F. Brown, Christian Sundberg, Ellen S. Morgan, Steven Jungles, Robert Carter, José Eduardo Krieger, E J Manseau, V S Harvey, Isabelle A. Eckelhoefer, Dian Feng, Ann M. Dvořàk, Richard C. Mulligan, Harold F. Dvorak - Laboratory Investigation 2000 cited by 416

  14. Long-Lived Antitumor CD8+ Lymphocytes for Adoptive Therapy Generated Using an Artificial Antigen-Presenting Cell

    Authors: Marcus O. Butler, Jeng-Shin Lee, Sascha Ansén, Donna Neuberg, F. Stephen Hodi, Andrew P. Murray, Linda Drury, Alla Berezovskaya, Richard C. Mulligan, Lee M. Nadler, Naoto Hirano - Clinical Cancer Research 2007 cited by 137

  15. Exogenous control of mammalian gene expression through modulation of RNA self-cleavage

    Authors: Laising Yen, Jennifer M. Svendsen, Jeng-Shin Lee, John T. Gray, Maxime Magnier, Takashi Baba, Robert J. D’Amato, Richard C. Mulligan - Nature 2004 cited by 271

  16. Pulmonary epithelial cell expression of GM-CSF corrects the alveolar proteinosis in GM-CSF-deficient mice.

    Authors: J.A. Huffman, William M. Hull, Glenn Dranoff, Richard C. Mulligan, J. A. Whitsett - Journal of Clinical Investigation 1996 cited by 262

  17. Generation of a high-titer retroviral vector capable of expressing high levels of the human beta-globin gene.

    Authors: Michel Sadelain, C H Wang, Michael Antoniou, F. Grosveld, Richard C. Mulligan - National Academy of Sciences, Proceedings of the National Academy of Sciences 1995 cited by 203

  18. Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene.

    Authors: Andrew C. Karaplis, A. Luz, Julie Glowacki, Roderick T. Bronson, Victor L. J. Tybulewicz, Henry M. Kronenberg, Richard C. Mulligan - Genes & Development 1994 cited by 1,159

  19. Physiological consequences of loss of plasminogen activator gene function in mice

    Authors: Peter Carmeliet, Luc Schoonjans, L Kieckens, Beverly Ream, Jay L. Degen, Roderick T. Bronson, Rita De Vos, Joost J. van den Oord, D Collen, Richard C. Mulligan - Nature 1994 cited by 1,057

  20. Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites

    Authors: Chris S. Lantz, Jürg Boesiger, Chang Ho Song, Nicolas Mach, Takahiko Kobayashi, Richard C. Mulligan, Yukifumi Nawa, Glenn Dranoff, Stephen J. Galli - Nature 1998 cited by 572

  21. Introduction of new genetic material into pluripotent haematopoietic stem cells of the mouse

    Authors: David A. Williams, Ihor R. Lemischka, David G. Nathan, Richard C. Mulligan - Nature 1984 cited by 534

  22. PPARα Deficiency in Inflammatory Cells Suppresses Tumor Growth

    Authors: Arja Kaipainen, Mark W. Kieran, Sui Huang, Catherine Butterfield, Diane R. Bielenberg, Gustavo Mostoslavsky, Richard C. Mulligan, Judah Folkman, Dipak Panigrahy - PLoS ONE 2007 cited by 98

  23. Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus

    Authors: Richard S. Mann, Richard C. Mulligan, David Baltimore - Cell 1983 cited by 1,851

  24. Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte–macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma

    Authors: Robert J. Soiffer, Thomas J. Lynch, Martin Mihm, Ken Jung, Catherine Rhuda, Jan C. Schmollinger, F. Stephen Hodi, Laura Liebster, Prudence Lam, Steven J. Mentzer, Samuel Singer, Kenneth K. Tanabe, A. Benedict Cosimi, Rosemary B. Duda, Arthur J. Sober, Atul K. Bhan, John Daley, Donna Neuberg, Gordon Parry, Joseph Rokovich, L. Willard Richards, Jan I.M. Drayer, Anton Berns, Shirley Clift, L. Cohen, Richard C. Mulligan, Glenn Dranoff - National Academy of Sciences, Proceedings of the National Academy of Sciences 1998 cited by 579